The Application segment of the Pygeum Africanum Powder‑Extract market is divided into four principal categories: urinary health, anti‑inflammatory, dermatological, and miscellaneous uses. Urinary health—primarily for benign prostatic hyperplasia (BPH) symptom relief—accounts for roughly 55 % of total revenue, driven by a mature patient base and consistent clinical endorsement. The anti‑inflammatory segment, representing about 25 % of sales, targets joint discomfort and systemic inflammation, leveraging emerging research on the extract’s cyclo‑oxygenase inhibition. Dermatological applications, contributing 12 % of the market, focus on wound healing and skin‑conditioning formulations, where the extract’s antioxidant profile is a differentiator. The remaining 8 % falls under miscellaneous uses, including nutraceuticals for hormonal balance and veterinary supplements. Together, these application categories shape the overall market size, with the urinary health line providing the bulk of volume while niche segments expand the product’s portfolio breadth. This detailed breakdown exemplifies the broader Pygeum Africanum Powder‑Extract segmentation framework used in industry reporting.